65 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
in the Territory) from any unauthorized or unlawful access, acquisition, use, disclosure, transmission, retention, processing, loss, destruction … claims, in writing, related to, any loss, theft, unauthorized access to, or unauthorized acquisition, modification, disclosure, retention, processing
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
with the acquisition of properties, assets or businesses; (e) all indebtedness of such Person created or arising under any conditional sale or other title retention
8-K
EX-2.1
y15xjmm6 xsywy
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
zywdk76mz
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
5sfzb0ih9
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
faru17rnf0pn id
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
ap3 27g76h0dbtb
16 Jun 23
Business combination disclosure
5:17pm
425
30d iu3ld
16 Jun 23
Business combination disclosure
5:16pm
425
38j3xff5opzlb4
16 Jun 23
Business combination disclosure
5:14pm
425
8xkrppg 2qqjfc4lfv1
16 Jun 23
Business combination disclosure
5:14pm
425
1jw muhqjx
16 Jun 23
Business combination disclosure
5:12pm
425
hil5e4n4y3uhn0mq9u20
16 Jun 23
Business combination disclosure
5:11pm